Structure and function of genome plasticity in human cancer
人类癌症基因组可塑性的结构和功能
基本信息
- 批准号:10297843
- 负责人:
- 金额:$ 50.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-12-13 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAllelesArchitectureBiologicalCancer BiologyCarcinogenesis MechanismCellsChemoresistanceChildChildhoodChildhood Solid NeoplasmChromatinChromatin Remodeling FactorClinicalCodeComplexDNADNA RepairDNA Sequence RearrangementDevelopmentElementsEngineeringEpigenetic ProcessFunctional disorderGene ExpressionGene RearrangementGenesGeneticGenetically Engineered MouseGenomeGenomic InstabilityGenomic approachGoalsHomologous GeneHumanHuman EngineeringKnowledgeLinkMalignant - descriptorMalignant NeoplasmsMissionMolecularMolecular TargetMouse StrainsMusMutationNatureNormal CellOncogenicOperative Surgical ProceduresOutcomePathway interactionsPatient-Focused OutcomesPatientsPeptide Signal SequencesPublic HealthRecurrenceRefractoryResearchResearch Project GrantsResistanceRhabdoid TumorSMARCB1 geneSignal TransductionSiteSolidSolid NeoplasmStructureTestingTherapeuticTransposaseTumor Suppressor GenesTumor-Suppressor Gene InactivationUnited States National Institutes of Healthbasecancer subtypescell transformationchemotherapychromatin remodelingfunctional genomicshuman diseaseimprovedin vivoin vivo Modelinhibitorinnovationinsightmetaplastic cell transformationmolecular targeted therapiesnovelphysiologic modelprogramsstem cellstreatment strategytumortumorigenesis
项目摘要
Project Summary
Despite intense efforts, the long-term cure rates of childhood and adult solid tumors such as rhabdoid tumors
are not satisfactory. Resistance to intensive chemotherapy is nearly universal, and targets for molecular
therapies are largely undefined. For example, inactivating mutations of SMARCB1 cause rhabdoid tumors, but
their molecular pathophysiology and genetics remain poorly understood. We have now found that the majority
of childhood and distinct adult solid tumors, including rhabdoid tumors, express PGBD5, a DNA transposase-
derived human gene. We have now found that human rhabdoid and numerous solid tumors are characterized
by previously unknown somatic deletions and inversions involving PGBD5-specific signal sequences (PSS) at
their breakpoints. Remarkably, PGBD5's DNA transposase enzymatic activity is both necessary and sufficient
for cell transformation, and induces recurrent and site-specific genomic rearrangements, leading to cooperative
inactivation of tumor suppressor genes. The central hypothesis of this proposal is that defining the genetic and
epigenetic mechanisms PGBD5-induced tumorigenesis will identify fundamental causes of PGBD5-induced
solid tumors and refractory rhabdoid tumors in particular. The applicant will test this hypothesis by
investigating the molecular mechanisms of PGBD5-induced cell transformation and rhabdoid tumorigenesis
using primary human and genetically-engineered mouse tumors. Aim 1 will elucidate genetic and epigenetic
mechanisms of PGBD5-induced cell transformation, with the goal of identifying PGBD5 targets that are
necessary for malignant transformation, and molecular mechanisms that control their induction. Aim 2 will
pursue the preliminary evidence that PGBD5-induced genomic rearrangements cooperate with SMARCB1
mutations in rhabdoid tumors and determine the function of PGBD5 using developmentally faithful mouse
rhabdoid tumor models in vivo. Successful completion of this project is expected to yield essential molecular
mechanisms of PGBD5-induced tumorigenesis, thus providing key insights into a fundamental biological and
clinical problem, which should have broad and lasting significance for understanding and treating solid tumors.
项目摘要
尽管付出了巨大的努力,但儿童和成人实体瘤(如横纹肌样瘤)的长期治愈率仍然很低,
并不令人满意。对强化化疗的耐药性几乎是普遍的,并且分子靶点是
治疗方法在很大程度上是不确定的。例如,SMARCB 1的失活突变导致横纹肌样瘤,但
它们的分子病理生理学和遗传学仍然知之甚少。我们现在发现,
儿童和不同成人实体瘤,包括横纹肌样瘤,表达PGBD 5,一种DNA转座酶,
衍生的人类基因。我们现在已经发现,人类横纹肌样瘤和许多实体瘤的特点是,
通过先前未知的涉及PGBD 5特异性信号序列(PSS)的体细胞缺失和倒位,
他们的断点。值得注意的是,PGBD 5的DNA转座酶活性是必要的,也是足够的。
细胞转化,并诱导复发性和位点特异性基因组重排,导致合作
肿瘤抑制基因的失活。这项建议的中心假设是,定义遗传和
表观遗传机制PGBD 5诱导的肿瘤发生将确定PGBD 5诱导的肿瘤发生的根本原因。
特别是实体瘤和难治性横纹肌样瘤。申请人将通过以下方式检验这一假设:
研究PGBD5诱导的细胞转化和横纹肌样肿瘤发生的分子机制
使用原代人类和基因工程小鼠肿瘤。目的1将阐明遗传和表观遗传
PGBD 5诱导的细胞转化的机制,目的是确定PGBD 5靶点,
恶性转化所必需的,以及控制其诱导的分子机制。目标2将
寻求PGBD5诱导的基因组重排与SMARCB 1合作的初步证据
横纹肌样肿瘤中的突变,并使用发育忠实的小鼠确定PGBD 5的功能
横纹肌样肿瘤模型。该项目的成功完成预计将产生必要的分子
PGBD5诱导的肿瘤发生机制,从而提供了一个基本的生物学和
这对认识和治疗实体瘤具有广泛而持久的意义。
项目成果
期刊论文数量(22)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Why do young people get cancer?
- DOI:10.1002/pbc.28335
- 发表时间:2020-07
- 期刊:
- 影响因子:3.2
- 作者:Kentsis A
- 通讯作者:Kentsis A
Germline SDHA mutations in children and adults with cancer.
- DOI:10.1101/mcs.a002584
- 发表时间:2018-08
- 期刊:
- 影响因子:1.8
- 作者:Dubard Gault M;Mandelker D;DeLair D;Stewart CR;Kemel Y;Sheehan MR;Siegel B;Kennedy J;Marcell V;Arnold A;Al-Ahmadie H;Modak S;Robson M;Shukla N;Roberts S;Vijai J;Topka S;Kentsis A;Cadoo K;Carlo M;Latham Schwark A;Reznik E;Dinatale R;Hechtman J;Borras Flores E;Jairam S;Yang C;Li Y;Bayraktar EC;Ceyhan-Birsoy O;Zhang L;Kohlman W;Schiffman J;Stadler Z;Birsoy K;Kung A;Offit K;Walsh MF
- 通讯作者:Walsh MF
Intracardiac Low-grade Sarcoma Following Treatment for Ewing Sarcoma.
尤文肉瘤治疗后的心内低度肉瘤。
- DOI:10.1097/mph.0000000000000754
- 发表时间:2017
- 期刊:
- 影响因子:0
- 作者:Ortiz,MichaelV;Magnan,Heather;Slotkin,EmilyK;Ambati,SrikanthR;Chou,AlexanderJ;Wexler,LeonardH;Meyers,PaulA;Walsh,MichaelF;Heaton,Todd;Girardi,LeonardN;Wolden,SuzanneL;Price,AnitaP;Kennedy,JenniferA;Zehir,Ahmet;Hameed
- 通讯作者:Hameed
Analytical Validation of Clinical Whole-Genome and Transcriptome Sequencing of Patient-Derived Tumors for Reporting Targetable Variants in Cancer.
- DOI:10.1016/j.jmoldx.2018.06.007
- 发表时间:2018-11
- 期刊:
- 影响因子:0
- 作者:Wrzeszczynski KO;Felice V;Abhyankar A;Kozon L;Geiger H;Manaa D;London F;Robinson D;Fang X;Lin D;Lamendola-Essel MF;Khaira D;Dikoglu E;Emde AK;Robine N;Shah M;Arora K;Basturk O;Bhanot U;Kentsis A;Mansukhani MM;Bhagat G;Jobanputra V
- 通讯作者:Jobanputra V
The piggyBac-derived protein 5 (PGBD5) transposes both the closely and the distantly related piggyBac-like elements Tcr-pble and Ifp2.
- DOI:10.1016/j.jmb.2021.166839
- 发表时间:2021-04-02
- 期刊:
- 影响因子:5.6
- 作者:Helou L;Beauclair L;Dardente H;Piégu B;Tsakou-Ngouafo L;Lecomte T;Kentsis A;Pontarotti P;Bigot Y
- 通讯作者:Bigot Y
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alex Kentsis其他文献
Alex Kentsis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alex Kentsis', 18)}}的其他基金
Structure and function of genome plasticity in human cancer
人类癌症基因组可塑性的结构和功能
- 批准号:
10054970 - 财政年份:2017
- 资助金额:
$ 50.95万 - 项目类别:
ABERRANT SIGNALING IN ACUTE MYELOID LEUKEMIA
急性髓系白血病中的异常信号传导
- 批准号:
10668471 - 财政年份:2016
- 资助金额:
$ 50.95万 - 项目类别:
ABERRANT SIGNALING IN ACUTE MYELOID LEUKEMIA
急性髓系白血病中的异常信号传导
- 批准号:
10480910 - 财政年份:2016
- 资助金额:
$ 50.95万 - 项目类别:
ABERRANT SIGNALING IN ACUTE MYELOID LEUKEMIA
急性髓系白血病中的异常信号传导
- 批准号:
10284204 - 财政年份:2016
- 资助金额:
$ 50.95万 - 项目类别:
Phosphoproteomic signatures for early detection and stratification of AML
用于 AML 早期检测和分层的磷酸化蛋白质组学特征
- 批准号:
8893365 - 财政年份:2015
- 资助金额:
$ 50.95万 - 项目类别:
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
HGF/MET 信号传导异常激活作为 AML 的治疗靶点
- 批准号:
8871431 - 财政年份:2015
- 资助金额:
$ 50.95万 - 项目类别:
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
HGF/MET 信号传导异常激活作为 AML 的治疗靶点
- 批准号:
8307367 - 财政年份:2011
- 资助金额:
$ 50.95万 - 项目类别:
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
HGF/MET 信号传导异常激活作为 AML 的治疗靶点
- 批准号:
8504821 - 财政年份:2011
- 资助金额:
$ 50.95万 - 项目类别:
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
HGF/MET 信号传导异常激活作为 AML 的治疗靶点
- 批准号:
8165860 - 财政年份:2011
- 资助金额:
$ 50.95万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 50.95万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 50.95万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 50.95万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 50.95万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 50.95万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 50.95万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 50.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 50.95万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 50.95万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 50.95万 - 项目类别: